Self-management of Chronic Mobility Limitations in MUHC Seniors

计划入组 60 人 · 首次发布于 2012 年 5 月 8 日

RAS-Peptide-Profile Study in Healthy Male Subjects

计划入组 12 人 · 首次发布于 2013 年 1 月 18 日

The Therapeutic Effect of Thalidomide in RI

计划入组 58 人 · 首次发布于 2017 年 7 月 5 日

RI-302

RI-962

RI-58

CVS Health CDR (CAD Hedged)

United States

MUSC Storm Eye Institute

United States

MUC Research GmbH

Germany

Canadian Institutes of Health Research Funds Four New Clinical Trials at RI-MUHC

A New Hope for Men with Metastatic Prostate Cancer

Perioperative Nivolumab and Neoadjuvant Immunotherapy Show Promise in Resectable NSCLC